ArticleOncogene2025
Targeting RBM39 suppresses tumor growth and sensitizes osteosarcoma cells to cisplatin.
Jingxuan Wang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this paperpooled itcites it
ArticleOncogene2025
Jingxuan Wang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.